Gene therapy as a form of molecular medicine is expected to have a major impact on medical treatments in the future. However, the clinical use of gene therapy today is hampered by inadequate gene delivering systems to ensure sufficient, accurate and safe DNA uptake in the target cells in vivo. Nonviral transfection methods might have the advantage of safe application, but it would be helpful to increase their transfection rates, especially in vivo. In this study, we show that focused ultrasound provides an enhanced transfer of DNA plasmids in vitro and in vivo. In vitro, the ␤-galactosidase and luciferase DNA reporter plasmid were transfected into four cell lines (NIH 3T3 fibroblasts, malignant melanoma Mewo, HeLa, Dunning prostate tumor R3327-AT1). Ultrasound induced a 55-(Mewo) to 220-fold (AT1) stimulation resulting in transfection efficiencies in vitro
Introduction
Gene therapy will be increasingly important for the treatment of inherited or acquired disorders, such as atherosclerosis and cancer. Nevertheless, major obstacles remain to be overcome before the expectations can be realized. One of the most critical areas of gene therapy is the design of an appropriate, accurate and effective gene vector that can be safely applied in vivo. [1] [2] [3] [4] [5] In the present study, we investigated whether focused ultrasound can be used as a physical tool to transfect cultured cells in vitro and in a prostate tumor on Copenhagen rats in vivo.
In principle, there are two major classes of vehicles for gene transfer: viral and nonviral vectors. To achieve localized gene transfer, viral vectors may take advantage of tissue-specific receptors 6 and tissue specific enhancers 7 that limit transcription to certain cell types. Although virus-based vectors account for most clinical trials, between 2% (Mewo) and 12% (AT1). The in vivo stimulation was assessed in the Dunning prostate tumor R3327-AT1 implanted subcutaneously in Copenhagen rats using the ␤-galactosidase reporter. After intratumoral DNA injection, focused ultrasound induced a 10-fold increase of ␤-galactosidase positive cells in histology and a 15-fold increase of ␤-galactosidase protein expression in the ELISA assay. In contrast, ultrasound was not found to enhance reporter gene expression after intravenous plasmid application. Because ultrasound waves can be focused on different anatomical locations in the human body without significant adverse effects, the control of DNA transfer by focused ultrasound is a promising in vivo method for spatial regulation of genebased medical treatments. Gene Therapy (2000) 7, 1516-1525.
nonviral vectors have certain advantages: they might be easier to prepare, can transfect quiescent cells, lack proteins invoking immunogenic responses, and lack limits in the size of genes that can be delivered. 4, 5, 8 Nonviral methods mostly used for standard in vitro laboratory transfection, including electroporation and calcium phosphate coprecipitation, are not suitable for general in vivo application despite encouraging reports for superficial tissue using electroporation as a transfection method. 9 On the other hand, direct tissue injection of naked DNA 8, 10 or injection of plasmids encapsulated in liposomes. 4, 5, 11, 12 are reliable and simple techniques for gene transfection that may have therapeutic potential, eg in cancer therapy. Plasmid DNA can be produced stably and cheaply to a high level of purity and with minimal risk of replication or viral incorporation. Accordingly, intratumoral cytokine gene transfer by gene guns has been reported to reduce tumor growth in vivo. 13 Moreover, a substantial level of gene expression was reported following less localized, i.v. delivery of plasmid vectors in vivo.
14 However, despite these advances, localized tumor gene therapy remains problematic with respect to clinical use.
A potential useful approach to this gene delivery problem could be ultrasound as a physical method to modulate gene transfer. Ultrasonic waves are in general non-ionizing mechanical waves as opposed to electro-magnetic waves. These mechanical waves or their subsequent interaction mechanisms with the tissue can alter the cell membranes and might thus be able to mediate the transfer of genes. Ultrasonic waves can be focused like optical waves to a target region. Thus it is possible to focus ultrasound noninvasively through the intact skin into the body, similar as in diagnostic ultrasound examinations for clinical use. Previous in vitro investigations have found that ultrasonic waves can permeabilize cell membranes and thus mediate the transfer of proteins through the skin 15 or molecules such as dextranes into the cell. 16 Similarly, lithotripter shock waves, a special form of ultrasound waves with high pressure amplitudes, have been shown to enhance the transfer of ribosome inactivating proteins into malignant cells in vivo. 17 Other in vitro reports indicate that genes can be transferred into mammalian cells 18 and plants 19 by ultrasound cleaning and sterilization equipment. In recent in vitro experiments sinusoidal ultrasound [20] [21] [22] and lithotripter shock waves were used to mediate plasmid DNA transfer into mammalian cells. 23 More recently, a report about in vivo transfection of melanoma cells by lithotripter shock waves has been encouraging. 24 However, lithotripter shock waves may also cause adverse effects such as hemorrhage and necrosis in the focal area, which has inspired research to use shock waves in cancer treatment. 25, 26 In general, the biological ultrasound effects, including transfection abilities, depend on parameters such as the pressure amplitude, intensity and pulse regime. [27] [28] [29] Unless the ultrasound method is used for local tumor therapy, where additional cytotoxicity might be helpful, adverse tissue effects should be avoided for transfection purposes.
For the present study we chose focused sinusoidal ultrasound for localized transfection because this application method had shown the highest transfection rates with less cytotoxicity in vitro. 29 Other advantages of focused sinusoidal ultrasound compared with alternative ultrasound applications are that the focus can be noninvasively positioned at variable depth and its size can be modified. 30, 31 In principle, all locations in the human body that can be accessed by percutaneous or endoluminal clinical diagnostic ultrasound devices are possible target sites. If the target volume exeeds the ultrasound focus, it can be sonicated by multiple exposures. Focused sinusoidal ultrasound has not been reported to mediate transfection to date. The specific question for this work was to investigate whether focused sinusoidal ultrasound could enhance the transfection efficiency of reporter plasmid DNA at an ultrasound intensity and pressure level suitable for noninvasive, in vivo, application without marked side-effects.
To this end, we first optimized in cell culture experiments the acoustical parameters to mediate the transfection of the ␤-galactosidase and luciferase reporter gene into several cell lines (NIH 3T3 fibroblasts, HeLa, prostate adenocarcinoma R3327-AT1 and human melanoma Mewo). The possibility of an in vivo transfection was then tested in one of the tested cell lines, the prostate adenocarcinoma R3327-AT1, which was transplanted to Copenhagen rats. Cytochemical ␤-galactosidase staining after direct plasmid injection into the tumor and intravenous injection was performed. To investigate the in vivo transfection capabilities of ultrasound further, ELISA assays were performed to quantify the protein levels of Gene Therapy the ␤-galactosidase reporter protein in the prostate tumors after intratumoral and intravenous reporter gene administration.
Results
In vitro transfection First, the in vitro transfection capabilities of focused ultrasound were investigated. The reaction vials with the prostate carcinoma cells (R3327-AT1) were mixed with the reporter plasmid and exposed to the ultrasonic field in a water tank to assure easy and optimal ultrasound coupling ( Figure 1) . To find the optimal ultrasound transfection conditions, 1 × 10 6 prostate carcinoma cells (R3327-AT1) cells and 1 g reporter plasmid DNA (␤-galactosidase) were mixed in 500 l PBS were used for each reaction. When the samples with the plasmids were sonicated in the center of the focus of the sound field, the ␤-galactosidase was strongly expressed, indicating successful DNA transfer. We found increasing transfection rates up to a 220-fold stimulation with increasing pressure amplitude from 0.1 to 1 MPa, while the percentage of viable cells decreased with higher pressure amplitudes to 5% at 5 MPa (Figure 2 ). The best ratio in terms of high stimulation and high cell viability was obtained at 1 MPa with a 80% viability. This pressure was applied in the following experiments, when the sonication time was varied. With increasing sonication time, the stimulation rate increased, reaching a plateau at 3 min, while the cell viability strongly decreased ( Figure 3 ).
In contrast, we found neither enhanced gene transfer nor enhanced cell death compared with the control cells when the vials with the plasmid DNA were placed outside the focus of the sound field at pressure amplitudes of less than 0.1 MPa. In the subsequent experiments this parameter set (1 MPa pressure amplitude, 100 Hz burst frequency, 4 ms burstlength, 3 min sonication time) was used.
To confirm independently the focused ultrasoundmediated in vitro transfection apart from the ␤-galactosidase reporter system, the luciferase gene (CMV-luci) was used as a reporter. Following administration of the luciferase gene to the prostate tumor cells under the same conditions as above, and applying the same sonication procedure as used for the ␤-galactosidase reporter system (1 MPa pressure amplitude, 100 Hz burst frequency, 4 ms burstlength, 3 min sonication time, 10 g plasmid DNA) the luciferase activity was compared between controls (DNA only), sonicated DNA solutions and that produced by the calcium phosphate transfection protocol (DNA and calcium phosphate, no sonication). Luciferase activity was 310-fold higher after ultrasound exposure than that in nonsonicated controls (Figure 4) . The luciferase activity induced by the standard calcium phosphate coprecipitation transfection method was only eight-fold higher than the ultrasound-induced luciferase activity.
We next tested whether cells of different origins could be transfected in vitro using the same ultrasound conditions. In an independent experimental series, the stimulation of NIH 3T3 fibroblasts, R3327-AT1 cells, Mewo cells and HeLa cells was compared using the ␤-galactosidase reporter gene. The baseline for the stimulation factor was the number of positive cells in each cell line with the DNA reporter only without sonication. In all experiments, transfection rates after ultrasound exposure were enhanced compared with these controls. Normalized to the individual control, we found a 85-fold stimulation for HeLa cells, a 75-fold stimulation for NIH 3T3 cells, a 220-fold stimulation for R3327-AT1 cells, and a 55-fold stimulation for Mewo cells ( Figure 5 ).
The corresponding transfection efficiencies in vitro were found to be be 2% (HeLa), 4% (NIH 3T3), 12% (R3327-AT1) and 3% (Mewo) at a cell viability ranging from 50% (Mewo) to 80% (R3327-AT1). Hence, in the focus of the soundfield, marked transfection efficiencies could be induced by focused ultrasound.
The ultrasound absorption by the reaction vials potentially increases the temperature in the vials. Therefore we measured the heat elevation in the vials during sonication and then we investigated in a separate experiment in a heated water bath the effect of heat alone on transfection with the ␤-galactosidase reporter system. We found that the temperature increased with increasing pressure and sonication time. Using the ultrasound setting used for the transfection experiments (1 MPa pressure amplitude, 100 Hz burst frequency, and 4 ms burst length), the temperature increase in the fluid was typically less than 1°C, if the thermocouple was inside the vials but without contact to the wall. If the thermocouple was in direct contact with the wall of the vials in the central axis of the ultrasound beam, a maximum temperature elevation of 10°C was detected. If the thermocouple was more than 3 mm off the center but directly at the vial wall, the increase was less than 2°C. Thus, the maximum temperature even directly at the vials did not exceed 35°C, because the in vitro experiments were performed at room temperature (25°C). For the subsequent transfection test, the vials (n = 5 for each temperature) were maintained at 25°C, 35°C, and 41°C, respectively, in the water tank for 3 min without sonication. 41°C was tested because we assumed that this was the maximum in vivo tumor temperature during sonication, since the core temperature of the animals was 36°C, and the maximum temperature elevation induced by ultrasound in ex vivo pig muscle as tissue model was measured to be 5°C. Normalized to the stimulation after the reporter gene incubation at 25°C, the stimulation at 35°C was 1.1 ± 0.28-fold (P Ͼ 0.4, t test) and at 41°C the stimulation was 1.3 ± 0.45-fold (P Ͼ 0.3, t test). Hence, the differences in the stimulation rates after heat exposure compared to the 25°C level were not significantly different indicating that heat alone had no marked influence on transfection efficiencies in the present system. 
Figure 7 Ultrasound-induced transfection in the Dunning prostate tumor R3327-AT1 in vivo. Relative number of ␤-galactosidase positive tumor cells in cytochemical staining in control animals, after sonication only (US), intratumoral DNA injection (i.t.), intratumoral DNA injection plus ultrasound (i.t. + US), intravenuous injection (i.v.), and intravenous injection plus ultrasound (i.v. + US). The normalized number was calculated by normalizing to the nonsonicated tumors injected with DNA solution only (means with s.e. bars for four to six tumors). The difference in the number of positive cells after intratumoral DNA injection with and without sonication were statistically significant (P Ͻ 0.02, LSD test).
sound induced a 10-fold increase in the mean number of ␤-galactosidase positive cells after intratumoral DNA plasmid injection compared with DNA injection only (P Ͻ 0.02, LSD test).
Especially after ultrasound application, some areas revealed more intensely stained cells and other areas revealed fainter blue cells. Fainter blue staining often appeared in the bordering areas of cells adjacent to intensely stained cells. No clear assignment to the physical ultrasound dosages could be made. The area with the most blue cells corresponded to the focal area of the sound field. In this area, approximately 5% of the tumor cells were stained positive for ␤-galactosidase activity. Figure 7 shows that control tumors without DNA injection or ultrasound only had no ␤-galactosidase positive, blue stained cells. Further, the ultrasound treatment without DNA did not result in positive staining. Interestingly, no ␤-galactosidase positive cells could be detected within the tumors by histology after intravenous DNA injection with or without sonication.
To obtain a more quantitative means of gene expression in the tumors after intratumoral or intravenuous reporter gene administration we used a ␤-galactosidase ELISA assay (Figure 8 ). Intratumoral DNA injection alone induced a significant level of ␤-galactosidase protein expression in tumors compared with controls (P Ͻ 0.05, LSD test). The additional ultrasound application enhanced this amount of ␤-galactosidase protein by a factor of approximately 15 after intratumoral injection (0.25 ± 0.1 versus 3.7 ± 0.9 ng ␤-galactosidase per milligram protein). This enhancement by ultrasound was significant (P Ͻ 0.02, LSD test). In contrast, after i.v. administration alone the protein levels were not significantly greater than in the control group (P Ͼ 0.3, LSD test). We could also not demonstrate with the ELISA assay that focused ultrasound leads to a significant level of reporter protein expression in the tumors after i.v. administration of the plasmid DNA (P Ͼ 0.2, LSD test).
As we had expected, ultrasound treatment alone without DNA did not influence the level of gene expression in the tumors compared with control.
In addition, in the same animals killed for tumor analysis, the skin covering the tumor and a specimen of the thigh muscle beyond the tumor were analyzed in a ␤-galactosidase ELISA assay. Neither after i.t. DNA injection nor after systemically i.v. DNA administration a significant increase of ␤-galactosidase protein expression was found compared with controls without DNA. Basically, the same negative results were found in skin and muscle tissue adjacent to tumors that received ultrasound where no significant ␤-galactosidase protein expression was measured. The only positive ␤-galactosidase value was measured in one skin sample (0.12 ng ␤-galactosidase per milligram protein) after intratumoral injection. In this tumor it had been noticed, however, during DNA injection that the skin was swelling indicating that some DNA solution was leaking to the surface of the tumor and artificially reached skin contact.
An
Discussion
This study shows that sinusoidal focused ultrasound can significantly enhance the transfection of plasmid DNA in the Dunning prostate tumor R3327-AT1 in vitro and in vivo after direct plasmid injection without marked sideeffects. This enhancement could be demonstrated by means of histological analysis, as well as by quantitation of gene expression using an ELISA assay.
First, we found that focused ultrasound in vitro enhanced the activity of ␤-galactosidase and luciferase in eukaryotic benign and malignant cells of different origins (NIH 3T3 fibroblasts, malignant melanoma Mewo, HeLa cells, and Dunning prostate tumor R3327-AT1). The doseresponse curve showed that increasing pressure amplitude and increasing sonication time produced higher stimulation (Figures 2 and 3) . For R3327-AT1 cells, up to a 220-fold stimulation was found by ␤-galactosidase staining, corresponding to an in vitro transfection efficiency of 12% ( Figure 5 ). Although this number seems to be promising, it is still beyond the value obtained with a standard transfection protocol, such as calcium phosphate coprecipitation, which showed an eight-fold higher luciferase activity than the ultrasound transfection procedure (Figure 4) . Moreover, comparing the results obtained by the ␤-galactosidase reporter system with those of the luciferase assay, we can conclude that the amount of protein expressed per cell by ultrasound transfection was lower than that after calcium phosphate coprecipitation.
Second, and probably the most important finding in this study, we found that, in vivo, in the Dunning tumor R3327-AT1, focused ultrasound induced a localized stimulation in all tumors after intratumoral ␤-galactosidase DNA injection (Figures 7 and 8) . The site of gene expression corresponded to the ultrasound focus. The average number of ␤-galactosidase positive cells in son-icated tumors was approximately 10-fold higher than that in non sonicated controls, resulting in an in vivo transfection efficiency of 5% after intratumoral DNA injection and ultrasound exposure. Tumors without DNA injection and tumors after intravenous DNA injection did not exhibit ␤-galactosidase activity.
This finding could be confirmed by a quantitative measurement of gene expression using a ␤-galactosidase ELISA assay. After intratumoral DNA injection the additional ultrasound application enhanced the amount of ␤-galactosidase protein by a factor of approximately 15 compared with DNA injection only. In contrast, after i.v. administration of the DNA we were not able to demonstrate significantly enhanced protein levels either in the tumors, in the skin or muscle adjacent to the tumor. Further, contrary to our hope, we could not demonstrate that the additional ultrasound treatment significantly enhances the reporter protein level in the tumors after i.v. DNA administration. While the lack of ultrasound effect in the skin and muscle tissue after systemic DNA application was not surprisingly because the focus of the sound field was aimed primarily in the tumor, the lack of measurable ultrasound effect in the tumors indicated that, if there were any enhancement of protein expression after localized ultrasound exposure, this effect appears to be very low.
Although we did not investigate the dynamics of the gene expression, or whether the transfection was stable or transient, we assume that the transfection was transient, as reported in other studies involving plasmid DNA. [8] [9] [10] [11] [12] [13] [14] 20 Also, the absolute number of the reported transfection efficiencies might vary since there was a 24 h interval between incubation with DNA/sonication and analysis. If cell proliferation takes place, transfected and nontransfected cells might divide not neccessarily at the same rate. However, we chose this efficiency calculation because it was a reasonable compromise for reliable quantification for the different settings.
We found less ultrasound transfected cells in vivo than in vitro. These differences in DNA uptake after the different administration modalities may have several explanations. One explanation may be poor intratumoral DNA distribution or the DNA outwash by blood flow. 32 A second explanation for the lower in vivo results might arise from the fact that the ultrasound focus (diameter 3 mm in the focal plane) was smaller than the tumor (median diameter 10 mm), while in vitro the cells are constantly mixed in the vials by the ultrasound resulting in a more complete exposure of the cells. This focus size further implies that in case of therapeutic application in a macroscopic, eg human tumor, several sonications had to take place to cover the entire tumor. A third explanation for the lower in vivo transfection might be related to the finding that no macroscopic or histological adverse effect could be detected in the tumor after sonication. In contrast, in the in vitro experiments, cell viability was only 80% after sonication, indicating that a higher ultrasound intensity might be necessary to increase the transfection effect in vivo by permeabilizing the cell membranes. A possible explanation for this result is that the threshold for cavitation in vivo is higher than in vitro. 27, [33] [34] [35] Cavitation, a non-thermal, oscillating bubble phenomenon in ultrasound fields might be important here, because it is the ultrasound interaction mechanism potentially responsible for transfection; 20, 22, 23 
thus, with
Gene Therapy the same ultrasound parameters used in vitro and in vivo, less cavitation was available in vivo to mediate transfection assuming cavitation is involved in the interaction process. A fourth explanation for the lower in vivo results might be attributed to the detection systems itself. Disadvantages of cytochemically ␤-galactosidase staining are the rare occurrence of big blue stains resulting from transfection into multiple nuclei. Fainter blue cells, in contrast, may represent an artifact of the cytochemical staining, in which the reacted product diffuses before precipitating. The alternative explanation would be that ␤-galactosidase can be transported through the tissue. Further, although the ELISA assay is sensitive for protein levels, the test has limitations in the low range especially with regard to the i.v. DNA application. Therefore, the failure to detect significant ␤-galactosidase reporter gene expression after i.v. administration may not necessarily imply that focused ultrasound in principle is unable to enhance the DNA uptake and gene expression after intravascular plasmid administration, but may rather be related to the small effect.
In principle, the efficiency of focused ultrasoundinduced transfection and thus the detectability can be increased in two ways: improve the ultrasound technique and improve the DNA presentation to the tumor cells.
The improvement of DNA administration can be achieved in several ways. First, higher DNA amounts than the 1 g used in vitro and the 10 g (CMV-LacZ) used for intratumoral injection could enhance both the ultrasound-mediated transfection efficiency and level of protein expression. Similarly, higher DNA concentrations in the vessel system might be necessary DNA to achieve significant results after i.v. administration. Furthermore, the interval between i.v. plasmid administration and sonication may have been not suitable with respect to DNAcell contact duration as a result of intravascular plasmid distribution or fast DNA degradadation.
Second, higher in vitro and in vivo transfection rates might be expected by complexing the DNA to cationic liposomes to shelter the DNA. 36 Third, reducing the blood flow could decrease DNA elimination and thus increase the contact duration with target cells. Finally, the DNA solution could be mixed with ultrasound contrast agents such as Albunex (Mallinckrodt Medical, St Louis, MO, USA) which has been shown to enhance the cavitation activity and thereby to enhance the ultrasoundinduced transfection in vitro. 37 The principal alternative route to increase the ultrasound-induced transfection efficiency asks for optimizing the ultrasound technique. For this purpose, it would be desirable to know the detailed interaction mechanisms between the ultrasound waves and the cells in vitro or in vivo to induce transfection. However, this mechanism is not yet understood. Ultrasound cell/tissue interaction mechanisms include nonthermal mechanical effects from high positive and negative ultrasound pressure waves, shear forces, and transient cavitation, defined as the existence of small bubbles. 27 Several groups have proposed the use of ultrasound either as lithotripter shock waves in vitro 23 and in vivo 24 or as nonfocused sinusoidal lowpressure ultrasound waves in vitro [20] [21] [22] as a method to enhance the transfection of plasmid DNA. Most authors considered cavitation as the dominant mechanism to induce transfection. In particular, shock wave-induced plasmid transfection has been ascribed to the cavitationtissue interaction mechanism. 23, 24, 29 However, cavitational activity, especially in lithotripter fields, is a highly nonlinear, statistical process that depends largely on the tissue properties, and is difficult to predict and to control. 27, 34, 35 In the present experiments, we therefore chose sinusoidal continuous wave ultrasound consisting of several bursts. Focused sinusoidal continuous-wave ultrasound is easier to control than lithotripter waves 23, 26, 34 and especially in a potential clinical setting it can be noninvasively guided by magnetic resonance imaging (MRI). 30, 31 The reason for this potential ultrasound focus guidance by MRI is that in the focal area of the ultrasound beam small physiological changes including temperature changes can be induced which can be localized by MRI measurements.
Sinusoidal burst ultrasound can produce relatively high pressure amplitudes in the range of 1 MPa while avoiding marked temperature increases associated with increasing ultrasound power and sonication time. To test whether the heat effect was responsible for the ultrasound-induced transfection in the present studies, vials were exposed to water bath hyperthermia. We found no transfection enhancement in the AT1 cells by heat up to 41°C, indicating that other ultrasound interaction mechanisms than heat were probably responsible for transfection enhancement. This maximum temperature of 41°C was tested because the maximum temperature elevation in ex vivo pig muscle was found to be 5°C which was then added to the body temperature of 36°C. The ultrasoundinduced temperature elevation should therefore not limit the application of focused ultrasound-mediated transfection in most tissues in vivo, where blood perfusion further decreases the potential temperature increase. Moreover, due to the short duration of the potential heat application in the range of a few minutes, the heat dose applied in the present tumor is below the dose showing no adverse effect in the same animal and tumor model in a recent study. 26 Nevertheless, focused ultrasound-induced gene transfection could be favorably combined with the thermal effects of focused ultrasound occurring at increasing intensities, especially in cancer therapy. MRI-guided noninvasive focused ultrasound therapy 30, 31 in combination with ultrasound induced transfer of drug-activating genes like the cytosine deaminase and the herpes simplex thymidine kinase gene 3 could result in an interesting locoregional tumor treatment option.
When comparing the sinusoidal focused ultrasound waves as a tool for transfection induction to alternatives, especially to ultrasound lithotripter shockwaves, it seems important to note that in the present studies, no complications with the animal occurred before, during, or after the sonication. Histological analysis revealed no marked tissue alterations after sonication compared with controls, either on the HE-stained tumors resected 72 h after the sonication, or on the X-gal-stained tumors resected 24 h after sonication. In particular, at the ultrasound entry or exit site of the tumor, no side-effects could be found, even though this was reported to be a common site of hemorrhage induced by lithotripter shockwaves. 25, 26 Thus we argue that the potential lithotripter side-effects (such as hemorrhage and tissue necrosis) together with difficulties in exact focusing and guidance in vivo might limit the use of lithotripter shockwaves as an in vivo transfection method to certain regions. Advantageous to in vivo application, sinusoidal focused ultrasound transfection appears to have no substantial side-effects and DNA itself is poorly immunogenic. 12 In addition, DNA and ultrasound can be delivered repeatedly, multiplying the effect even if a single application shows only limited therapeutic benefit.
A final conclusion about the optimal ultrasound technique for in vivo application in terms of ultrasound pressure, burst frequency, burst length, focusing modus and sonication time has not been systematically determined here. Moreover, to make this approach more complicated, our in vitro data suggest that different cell lines might differ in their transfection response to ultrasonic waves.
At this point, for potential clinical transfection applications, focused ultrasound is an interesting research tool. It can noninvasively direct energy to a defined area superficially or deeply situated in the body. 31 Ultrasound can influence the physiological tissue conditions leading to cell alterations that result in enhanced permeability of the cell membrane for large molecules without causing cell death. [15] [16] [17] Restrictions occur by wave reflection and significant temperature increase at bone or air interfaces. [27] [28] [29] [30] [31] There are two possible ways of DNA administration before sonication. First, the direct injection into solid organs, which may include liver, 38 muscle, 10 skin, 12 as well as potentially prostate and breast. Second, systemic or regional DNA application into the blood vessel system if the plasmids can be sheltered as by liposomes. If the DNA is stable enough and the DNA containing solution can be isolated in a ligated vessel, we speculate that the blood vessel system could itself be a target for ultrasound-induced transfection. 39 The aim of such an application could be to aid in the therapy of proliferative vascular diseases as suggested in a report demonstrating ultrasound-enhanced gene expression in vascular smooth muscle cells in vitro. 40 In summary, we have demonstrated that focused ultrasound can enhance transfer of DNA plasmids in vitro into several cell lines and in vivo into the Dunning prostate tumor after direct DNA injection. Because ultrasound waves can be focused on different anatomical locations in the human body without significant adverse effects, this physical method of gene delivery might be useful to achieve a regionally enhanced DNA uptake in humans. Thus, focused ultrasound represents a promising novel method of spatial control of in vivo gene therapy strategies.
Materials and methods

Ultrasound generation
To study the transfection efficiency for plasmid DNA in vitro, we used an experimental piezoelectric ultrasound device by which a wide range of ultrasound parameters could be applied (Figure 1 ). The ultrasound waves were generated by a piezoceramic, air-backed disc transducer with a diameter of 10 cm, mounted with its radiating face parallel to the side wall of the tank. The transducer was fed with a sinusoidal RF-signal (carrier frequency 118 MHz) generated by a function generator (Philips PM5134; Hilversum, The Netherlands) and amplified by an RFamplifier (ENI 3200L; Rochester, NY, USA). The plane waves were focused with a polystyrene lens (focal length, f = 126 mm) and coupled into a 40 l water tank filled with deionized and partly degassed water (O 2 content 15 mg/l, Merck-Oxygen test).
The ultrasonic pressure field was measured by commercially available calibrated needle hydrophones (SEA, Milpitas, CA, USA and Imotec, Wuerselen, Germany). At 1 MPa pressure amplitude the focus (−6 dB area) in the water was rotational-elliptic, 3 cm long in the ultrasound propagation direction and 0.3 cm wide at the value where the pressure is 50% of its maximum.
The cells were exposed to several independent bursts, each consisting of sinusoidal continuous-wave ultrasound. Burst ultrasound was used to avoid marked temperature elevation induced by energy absorption. Simultaneously, burst ultrasound allowed relatively high ultrasound pressure amplitudes similar to those continuous waves used to induce hyperthermia in local cancer therapy. [27] [28] [29] [30] [31] A burst frequency of 100 Hz was used, since this frequency was reported to produce the optimal transfection efficiency for cells in culture including two human prostate cancer cell lines. 21, 29 Furthermore, we varied the pressure amplitude, referring to the positive pressure amplitude in the focus of the undisturbed sound field in water (0.1 to 5 MPa) and the total sonication time (10 s to 10 min). The pressure amplitude of 1 MPa, the total sonication time of 3 min, and the burst length of 4 ms were chosen for the further experiments because this combination had shown the optimal ratio of stimulation and cell viability. The spatial peak intensity in the focus during the burst was approximately 33 W/cm 2 at 1 MPa peak pressure in the focus of the undisturbed sound field in water. Accordingly, the average intensity (spatial peak temporal intensity I-SPTA) over the 3-min sonication period was approximately 13.2 W/cm 2 . For temperature measurements in the water tank and during sonication inside and outside the reaction vials, K-type thermocouples (Ebro, Hagen, Germany) were used. Temperature measurements were also carried out in fresh, ex vivo pig muscle. For temperature measurement, the pig muscle (8 × 8 × 12 cm 3 ) was placed in the focus of the sound field in the water tank at room temperature. We obtained a maximum temperature elevation of 5°K applying the same ultrasound protocol (1 MPa, 100 Hz, 4 ms, 3 min) used for transfection.
Animal model and tumor system
The Dunning prostate tumor R3327, which is available in several sublines, was used as a biological model. The R3327-AT1 subline, 41 supplied to us by Dr JT Isaacs (Johns Hopkins University, Baltimore, MD, USA), represents a hormone-independent anaplastic carcinoma of the prostate with a labeling index (LI) of 70 ± 05% and 88 ± 37% measured with flow cytometry and histology, respectively, an S-phase duration (T s ) of 8 h, a potential doubling time T pot of 47 days, and a cell-loss factor of 15%. 42 In addition, the tumor has only low antigeneity and does not spontaneously develop marked central necrosis. Fresh pieces of tumor tissue (2 × 2 × 2 mm 3 ) from an animal serving as tumor donator were transplanted subcutaneously into both thighs of young male adult Copenhagen rats (Harlan Sprague-Dawley, Indianapolis, IN, USA).
The tumors were sonicated after direct intratumoral (i.t.) or intravenuous (i.v.) DNA injection 15 to 20 days Gene Therapy after transplantation, when the tumor volume was 0.8 to 1.3 cm 3 and the median tumor diameter was 1 cm. All procedures were carried out under anesthesia with Ketavet (Parke Davis, Morris Plains, NJ, USA; 0.9 g/kg, i.p.) and Rompun 2% solution (Bayer, Leverkusen, Germany; 0.3 g/kg, i.p.). To achieve reproducible ultrasonic coupling properties and to avoid bubble interference, the tumor area was shaved and treated with depilatory cream before sonication. All experiments were approved by an external animal protection committee, and animals were maintained according to the guidelines for laboratory animals at the German Cancer Research Center (DKFZ, Heidelberg, Germany) established by the German government.
Cell culture
We used HeLa cells, Mewo cells (human melanoma), NIH 3T3 fibroblasts, and Dunning prostate rat adenocarcinoma cells (subline R3327-AT1). The R3327-AT1 cells were isolated from tumors and supplied from stock to avoid genetic shift. All cells were kept in Dulbecco's modified Eagle's medium/glutamax (Life Technologies, Karlsruhe, Germany) supplemented with 10% fetal bovine serum and penicillin/streptomycin.
Plasmids and reporter assays
Reporter constructs were two derivatives of RC/CMV (Invitrogen, Groningen, The Netherlands) that express the reporter genes luciferase (CMV-luci) or bacterial ␤-galactosidase (CMV-lacZ) under the control of the cytomegalovirus promotor. The cells were sonicated in suspension, plated out after the sonication to adhere and analyzed for gene expression 24 h later. The cells were fixed with 2% paraformaldehyde-0.2% glutaraldehyde, washed three times in PBS, and then stained with X-gal buffer (1 mg/ml 5-bromo-4-chloro-3-indoxyl ␤-galactoside, 5 mm K 3 Fe(CN) 6 , 5 mm K 4 Fe(CN) 6 , 2 mm MgCl 2 ). The ␤-galactosidase positive, blue cells were counted on each dish using a grid. The fold stimulation was calculated as the number of blue cells divided by the number of blue cells of nonsonicated control cells that were mixed with plasmids only. The transfection efficiency was calculated as the number of blue cells divided by the total number of cells in the beginning of the experiments.
Conditions for the luciferase assays were as described (Luciferase assay system, Promega, Mannheim, Germany). Light output was measured using a luminometer (type LB 9501, Berthold, Pforzheim, Germany). The luciferase assay was normalized by the given number of cells.
To investigate the effect of a 5°K temperature elevation alone on the transfection rates, vials with plasmid were maintained at 25°C, 35°C and 41°C, respectively. The 41°C value was chosen because the core temperature of the Copenhagen rats was 36°C. 26 Ultrasound-mediated transfection in vitro The ultrasound waves were focused by a lens and coupled into a watertank (Figure 1 ) because many tissues have in vivo properties similar to water with respect to ultrasound propagation. 27, 28 In dose-effect experiments, R3327-AT1 cells were used to investigate the ultrasound settings for optimal transfection efficiency. The vials with the cells mixed with plasmid DNA containing ␤-galactosidase as reporter were exposed to the ultrasonic field inside the water tank.
For each reaction, 1 × 10 6 cells and 1 g reporter plasmid DNA were mixed in 500 l PBS in 1.5 ml commercially available reaction vials and directly thereafter exposed to the ultrasonic field in the water tank at room temperature (25°C). The vials were attached at the holder of a positioning system with their cover to avoid significant interferences with the sound field as verified by the needle hydrophones. With this positioning system the vials could be moved in x, y, and z directions in the water tank. Cells were stained with trypan blue (0.4%, Life Technologies) to test their integrity immediately after the sonication. Other cells were plated out and 24 h after sonication, the transfection rates were evaluated with ␤-galactosidase staining and luciferase assays.
Ultrasound-mediated transfection in vivo
The same ultrasound equipment and water tank described above were used for the in vivo experiments. During sonication, the anesthetized animals were restrained in a polyacrylic plastic tube that was positioned in the water tank via the same positioning system used for the vials. The water temperature was maintained at 36°C. The tumor-bearing leg was projected into the water through a hole in the polyacrylic jig and fixed by a thread. For sonication, the center of the tumor was positioned in the geometrical focus of the soundfield ( Figure  1 ) such that the central axis of the ultrasound propagation did not interfere either with parts of the animal body or with the plastic tube on the entry or exit site of the tumor. Control tumors were positioned in the water bath in the same way without being sonicated.
The tumors were injected with 10 g of CMV-LacZ DNA in 50 l PBS 3 min before sonication. The injection was performed into the center of the tumor and the needle was slowly moved during the injection to ensure broad distribution and to avoid intratumoral bleeding or mechanical tumor alterations. To avoid leakage of the DNA solution via the canulation due to the tumor turgor, we had tested in pretests the best way to perform the intratumoral injection. We had found that, if the needle remains still for 2 to 3 min before removing the needle, the solution remains in the tumor. For intravenous application 100 g of CMV-LacZ DNA in 500 l PBS were injected into the tail vein of the animal 3 min before the sonication.
For cytochemical analysis the tumors were resected 24 h after sonication, fixed in buffered formalin, and embedded in paraffin. Tissue slices (4-6 m) were stained with X-gal buffer and counterstained with neutral red. The stimulation was assessed by counting the blue cells on the histological slices using a grid. Corresponding representative areas of 5 mm 2 were compared, where the most blue cells on the individual slice could be detected. Differences in the number of transfected cells and the site and geometry of the gene expression area were detected with cytochemical staining.
Three additional tumors were only sonicated, resected 72 h after treatment and stained with hematoxylineosin (HE).
Beta-galactosidase protein concentration was quantified using an ELISA (3 Prime-5 Prime, Boulder, CO, USA) according to the instructions of the manufacturer. Using the same biological model, ultrasound conditions and plasmid applications as for the histology, another set of experiment was performed. The tumors were harvested 24 h after sonication and frozen in liquid nitrogen. For comparison, in these animals the skin covering the tumor as well as a piece of thigh muscle adjacent to the tumor were also analyzed. The tissues were ground to powder and cell lysates were prepared using lysis buffer (10 mm Tris-Cl, pH 8, 1 mm PMFS, 1 g/ml Aprotinin). Tissue debris was pelleted by centrifugation at 14 000 g and total protein concentration was determined using the Bradford assay (BioRad Laboratories, Richmond, CA, USA). Absorbance values were quantitated using an ELISA plate reader at a wavelength of 405 nm. ␤-Galactosidase protein quantity was determined as ng ␤-galactosidase per milligram protein. All tissue samples were measured in triplicates.
Statistical analysis
Fisher's exact test was used to analyze proportions and Student's t test was used to compare means. For multiple comparisons analysis of variance (ANOVA) was used with Fisher's least significant difference (LSD) method. In general, in vitro sample size was four to five samples for each condition and in vivo sample size was four to seven tumors per condition. All analyses were performed with the Statistica 5.0 software program, 43 and all tests were two-tailed.
